Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: future royalty payments

And now that I've turned this into another friggin' novel, I'll suggest that we may see several more licensees over the next few weeks. I think this not only because of the end of formal litigation and what that implies, but also to further disguise the "J Numbers" if any forward-looking guidance comes with the 10Q.

I hope you are right, and to really hide big numbers many more licensees in the near future.

Thanks for as always an interesting read.

glta

Tom

Share
New Message
Please login to post a reply